Application of bone growth factors-the potential of different carrier systems

Oral and Maxillofacial Surgery

Volumn 14, Issue 1, 2010, Pages 17-22

  Schliephake, Henning ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Biomaterials; Carriers; Growth factors; Osteoinduction; Regenerative medicine

Indexed keywords

BIOMATERIAL; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; DRUG CARRIER;

ADSORPTION; ANIMAL; BONE DEVELOPMENT; BONE REGENERATION; DELAYED RELEASE FORMULATION; DRUG EFFECT; DRUG IMPLANT; HUMAN; REVIEW;

ADSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG IMPLANTS; HUMANS; OSTEOGENESIS;

EID: 76649083249     PISSN: 18651550     EISSN: 18651569     Source Type: Journal    
DOI: 10.1007/s10006-009-0185-1     Document Type: Review

References (43)

1. Adden N, Gamble LJ, Castner DG, Hoffmann A, Gross G, Menzel H (2006) Phosphonic acid monolayers for binding of bioactive molecules to titanium surface. Langmuir 22: 8197-8204.
2. Arosarena O, Collins W (2005) Comparison of BMP-2 and -4 for rat mandibular bone regeneration at various doses. Orthod Craniofac Res 8: 267-276.
3. Bernhardt R, van den Dolder J, Bierbaum S, Beutner R, Scharnweber D, Jansen J, Beckmann F, Worch H (2005) Osteoconductive modifications of Ti-implants in a goat defect model: characterization of bone growth with SR muCT and histology. Biomaterials 26(16): 3009-3019.
4. Bierbaum S, Douglas T, Hanke T, Scharnweber D, Tippelt S, Monsees TK, Funk RH, Worch H (2006) Collageneous matrix coatings on titanium implants modified with decorin and chondroitin sulfate: characterization and influence on osteoblastic cells. J Biomed Mater Res A 77(3): 551-562.
5. Chen B, Lin H, Wang J, Zhao Y, Wang B, Zhao W, Sun W, Dai J (2007) Homogenous osteogenesis and bone regeneration by demineralised bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials 28: 1027-1035.
6. Docherty Skogh AC, Engstrand T (2009) Bone morphogenetic proteins in cranial reconstructions: clinical evaluation of heparin-chitosan as a carrier for BMP-2. Plast Reconstr Surg 123(6): 192e-193e.
7. Engstrand T, Veltheim R, Arnander C, Docherty-Skogh AC, Westermark A, Ohlsson C, Adolfsson L, Larm O (2008) A novel biodegradable delivery system for bone morphogenetic protein-2. Plast Reconstr Surg 121(6): 1920-1928.
8. Eufinger H, Rasche C, Lehmbrock J, Wehmöller M, Weihe S, Schmitz I, Schiller C, Epple M (2007) Performance of functionally graded implants of polylactides and calcium phosphate/calcium carbonate in an ovine model for computer assisted craniectomy and cranioplasty. Biomaterials 28(3): 475-485.
9. Friess W, Uludag H, Foskett S, Biron R, Sargeant C (1999) Characterization of absorbable collagen sponges as rhBMP-2 carriers. Int J Pharm 187: 91-99.
10. Gruber RM, Weich H, Schliephake H (2009) Ectopic bone formation after implantation of a slow release system of polylactid acid and rhBMP2. Clin Oral Impl Res 20(1): 24-30.
11. Hall J, Sorensen RG, Wozney JM, Wikesjö UM (2007) Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model. J Clin Periodontol 34(5): 444-451.
12. Jeon O, Song SJ, Kang SW, Putnam AJ, Kim BS (2007) Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials 28(17): 2763-2771.
13. Jung RE, Hämmerle CH, Kokovic V, Weber FE (2007) Bone regeneration using a synthetic matrix containing a parathyroid hormone peptide combined with a grafting material. Int J Oral Maxillofac Implant. 22(2): 258-266.
14. Jung RE, Cochran DL, Domken O, Seibl R, Jones AA, Buser D, Hammerle CH (2007) The effect of matrix bound parathyroid hormone on bone regeneration. Clin Oral Implants Res 18(3): 319-325.
15. Jung RE, Weber FE, Thoma DS, Ehrbar M, Cochran DL, Hämmerle CH (2008) Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate. Clin Oral Implants Res 19(2): 188-195.
16. Karageorgiou V, Meinel L, Hofmann S, Malhotra A, Volloch V, Kaplan D (2004) Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 71(3): 528-537.
17. Karageorgiou V, Tomkins M, Fajardo R, Meinel L, Snyder B, Wade K, Chen J, Vunjak-Novakovic G, Kaplan DL (2006) Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A 78(2): 324-334.
18. Kilian O, Wenisch S, Karnati S, Baumgart-Vogt E, Hild A, Fuhrmann R, Jonuleit T, Dingeldein E, Schnettler R, Franke RP (2008) Observations on the microvasculature of bone defects filled with biodegradable nanoparticulate hydroxyapatite. Biomaterials 29(24-25): 3429-3437.
19. Kirker-Head C, Karageorgiou V, Hofmann S, Fajardo R, Betz O, Merkle HP, Hilbe M, von Rechenberg B, McCool J, Abrahamsen L, Nazarian A, Cory E, Curtis M, Kaplan D, Meinel L (2007) BMP-silk composite matrices heal critically sized femoral defects. Bone 41(2): 247-255.
20. Kloss FR, Gassner R, Preiner J, Ebner A, Larsson K, Hächl O, Tuli T, Rasse M, Moser D, Laimer K, Nickel EA, Laschober G, Brunauer R, Klima G, Hinterdorfer P, Steinmüller-Nethl D, Lepperdinger G (2008) The role of oxygen termination of nanocrystalline diamond on immobilisation of BMP-2 and subsequent bone formation. Biomaterials 29(16): 2433-2442.
21. Michael J, Beutner R, Hempel U, Scharnweber D, Worch H, Schwenzer B (2007) Surface modification of titanium-based alloys with bioactive molecules using electrochemically fixed nucleic acids. J Biomed Mater Res Part B: Appl Biomater 80 B: 146-155.
22. Min BM, Lee G, Kim SH, Nam YS, Lee TS, Park WH (2004) Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal kerainocytes and fibroblasts in vitro. Biomaterials 25: 1289-1297.
23. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R (1996) Novel approach to fabricate porous sponges of poly(D, L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 17: 1417-1422.
24. Park YJ, Kim KH, Lee JY, Ku Y, Lee SJ, Min BM, Chung CP (2006) Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration. Biotechnol Appl Biochem 43(Pt 1): 17-24.
25. Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19: 1029-1034.
26. Schiffman JD, Schauer CL (2007) Cross-linking chitosan nanofibers. Biomacromolecules 8(2): 594-601.
27. Schiller C, Rasche C, Wehmöller M, Beckmann F, Eufinger H, Epple M, Weihe S (2004) Geometrically structured implants for cranial reconstruction made of biodegradable polyesters and calcium phosphate/calcium carbonate. Biomaterials 25: 1239-1247.
28. Schliephake H, Scharnweber D (2008) Chemical and biological functionalization of titanium for dental implants. J Mater Chem 18: 2404-2414.
29. Schliephake H, Scharnweber D, Dard M, Rössler S, Sewing A, Hoogestraat D (2002) The effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest-an experimental pilot study in dogs. Clin Oral Impl Res 13: 312-319.
30. Schliephake H, Aref A, Scharnweber D, Dard M, Sewing A (2005) Effect of immobilized BMP2 coating of titanium implants on periimplant bone formation. Clin Oral Impl Res 16(5): 563-569.
31. Schliephake H, Weich HA, Schulz J, Gruber R (2007) In-vitro characterization of a slow release system of polylactic acid and rhBMP2. J Biomed Mater Res 83: 455-462.
32. Schliephake H, Weich H, Dullin C, Gruber R, Frahse S (2008) Mandibular reconstruction by implantation of rhBMP in a slow release system of polylactic acid. Biomaterials 2(9): 103-110.
33. Seol YJ, Park YJ, Lee SC, Kim KH, Lee JY, Kim TI, Lee YM, Ku Y, Rhyu IC, Han SB, Chung CP (2006) Enhanced osteogenic promotion around dental implants with synthetic binding motif mimicking bone morphogenetic protein (BMP)-2. J Biomed Mater Res A 77(3): 599-607.
34. Sofia S, McCarthy MB, Gronowicz G, Kaplan DL (2001) Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res 54(1): 139-148.
35. Steffens GC, Yao C, Prével P, Markowicz M, Schenck P, Noah EM, Pallua N (2004) Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng 10(9-10): 1502-1509.
36. Steinmüller-Nethl D, Kloss FR, Najam-Ul-Haq M, Rainer M, Larsson K, Linsmeier C, Köhler G, Fehrer C, Lepperdinger G, Liu X, Memmel N, Bertel E, Huck CW, Gassner R, Bonn G (2006) Strong binding of bioactive BMP-2 to nanocrystalline diamond by physisorption. Biomaterials 27(26): 4547-4556.
37. Suzuki A, Terai H, Toyoda H, Namikawa T, Yokota Y, Tsunoda T, Takaoka K (2006) A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein-2: a potential treatment for infected bone defects. J Orthop Res 24(3): 327-332.
38. Tschakaloff A, Von Oepen R, Seibt S, Vieting M (1996) Das Begasungsverfahren zur Beladung resorbierbarer Polymere mit thermolabilen Substanzen. Dtsch Z Mund Kiefer GesichtsChir 20: 47-50.
39. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J (1999) Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 46(2): 193-202.
40. Uludag H, D'Augusta D, Golden J, Li J, Timony G, Riedel R, Wozney JM (2000) Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J Biomed Mater Res 50: 227-238.
41. Uludag H, Gao T, Porter TJ, Friess W, Wozney JM (2001) Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Joint Surg 83AS1: 128-135.
42. Weber FE, Eyrich G, Grätz KW, Maly FE (2002) Sailer. Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres. HF. Int J Oral Maxillofac Surg 31(1): 60-65.
43. Yao C, Roderfeld M, Rath T, Roeb E, Bernhagen J, Steffens G (2006) The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices. Biomaterials 27: 1608-1616.